Latest news
Veracyte: Diagnostics With Favorable Economics (NASDAQ:VCYT) - Seeking AlphaSeeking Alpha · Mon, 10 Aug 2026 13:32:02 GMTVeracyte reports strong Q2 2026 growth, evolvin... - PluangPluang · Mon, 10 Aug 2026 04:23:00 GMTVeracyte: Core Growth Funds Prosigna And TrueMRD (NASDAQ:VCYT) - Seeking AlphaSeeking Alpha · Mon, 10 Aug 2026 03:30:12 GMTVeracyte (VCYT) Is Down 18.2% After Raising 2026 Revenue Guidance on New Cancer Tests - SahmSahm · Tue, 04 Aug 2026 07:00:00 GMT